Id |
Subject |
Object |
Predicate |
Lexical cue |
T14 |
0-24 |
DOID_0080600 |
denotes |
Coronavirus disease 2019 |
T1 |
26-34 |
DOID_0080600 |
denotes |
COVID-19 |
T2 |
116-124 |
DOID_0080600 |
denotes |
COVID-19 |
T15 |
191-219 |
HP_0001626 |
denotes |
Cardiovascular comorbidities |
T3 |
241-249 |
DOID_0080600 |
denotes |
COVID-19 |
T4 |
283-294 |
HP_0012819 |
denotes |
myocarditis |
T5 |
283-294 |
DOID_820 |
denotes |
myocarditis |
T6 |
377-391 |
CHEBI_35457 |
denotes |
ACE inhibitors |
T16 |
396-425 |
CHEBI_61016 |
denotes |
angiotensin receptor blockers |
T10 |
450-462 |
DOID_10763 |
denotes |
hypertension |
T9 |
450-462 |
HP_0000822 |
denotes |
hypertension |
T11 |
467-480 |
HP_0001635 |
denotes |
heart failure |
T12 |
484-492 |
DOID_0080600 |
denotes |
COVID-19 |
T13 |
562-570 |
DOID_0080600 |
denotes |
COVID-19 |
R10 |
T10 |
T6 |
negative |
hypertension,ACE inhibitors |
R11 |
T10 |
T6 |
negative |
hypertension,ACE inhibitors |
R12 |
T16 |
T9 |
negative |
angiotensin receptor blockers,hypertension |
R13 |
T16 |
T11 |
negative |
angiotensin receptor blockers,heart failure |
R14 |
T6 |
T10 |
negative |
ACE inhibitors,hypertension |
R15 |
T6 |
T11 |
negative |
ACE inhibitors,heart failure |
R16 |
T15 |
T3 |
effect |
Cardiovascular comorbidities,COVID-19 |
R17 |
T5 |
T3 |
effect |
myocarditis,COVID-19 |
R18 |
T5 |
T12 |
effect |
myocarditis,COVID-19 |
R19 |
T15 |
T12 |
effect |
Cardiovascular comorbidities,COVID-19 |
R20 |
T15 |
T13 |
effect |
Cardiovascular comorbidities,COVID-19 |
R21 |
T15 |
T2 |
effect |
Cardiovascular comorbidities,COVID-19 |
R22 |
T15 |
T1 |
effect |
Cardiovascular comorbidities,COVID-19 |
R23 |
T15 |
T14 |
effect |
Cardiovascular comorbidities,Coronavirus disease 2019 |
R24 |
T5 |
T13 |
effect |
myocarditis,COVID-19 |
R25 |
T5 |
T2 |
effect |
myocarditis,COVID-19 |
R26 |
T5 |
T1 |
effect |
myocarditis,COVID-19 |
R27 |
T5 |
T14 |
effect |
myocarditis,Coronavirus disease 2019 |